Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 257

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 19
Chunk 257
---
12, 2024, 80,526 23,197

  On January 16, 2024, the Company issued 1,500,000 warrants with an exercise price of $ 1.60 per warrant in connection with its January 2024 Public Offering (“ January 2024 Warrants”). Each warr...  
  During the year ended October 31, 2024, the Company recorded a gain on the revaluation of the total derivative warrant liabilities of $ 707,802 in the Consolidated Statements of Operations and ...  

F-22

CLEARMIND
MEDICINE INC.

Notes to
the Consolidated Financial Statements

(Expressed
in United States Dollars)

  Derivative                       

  The                                                                                                  

                               October 31,                         
  Share Price                  $                1.39               
  Exercise Price               $                1.077 -$ 1.60      
  Expected life                                 3.43 - 4.21 years  
  Risk-free interest rate                       4.13 - 4.14        
  Dividend yield                                0.00               
  Expected volatility                           143.59 - 147.59    

Expected
volatility was determined by calculating the historical volatility of the Company’s share price and comparison companies’ standard
deviation over the previous 4.21

  The                                                                               
  following table presents the changes in the warrant liability during the period:  
 ────────────────────────────────────────────────────────────────────────────────────

  Balance as of November 1, 2022                    -  
 ───────────────────────────────────────────────────────
  Issuance of April 2023 Warrants           1,771,208  
  Issuance of September 2023 Warrants         923,225  
  Exercise of warrants                      ( 574,040  
  Changes in fair value of warrants         2,189,986  
  Balance as of October 31, 2023            4,310,379  
  Issuance of January                         480,004  
  Exercise of warrants                     ( 562,879)  
  Changes in fair value                    ( 707,802)  
  Balance as of October 31, 2024            3,519,702  

F-23

CLEARMIND
MEDICINE INC.

Notes to
the Consolidated Financial Statements

(Expressed
in United States Dollars)

  Share    

  The Company’s authorized share